[HTML][HTML] Clinical characteristics of coronavirus disease 2019 in China

…, C Ou, J He, L Liu, H Shan, C Lei… - New England journal …, 2020 - Mass Medical Soc
Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …

[HTML][HTML] Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

…, J Xiang, Y Hu, L Liu, H Shan, C Lei… - European …, 2020 - Eur Respiratory Soc
… Li, Hong Shan, Chun-liang Lei, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng,
Jian-ming Wang, Ji-yang Liu, Zhong … Conflict of interest: Chun-liang Lei has nothing to disclose. …

[HTML][HTML] Clinical characteristics of 2019 novel coronavirus infection in China

…, Z Ni, Y Hu, W Liang, C Ou, J He, L Liu, H Shan, C Lei… - MedRxiv, 2020 - medrxiv.org
Background Since December 2019, acute respiratory disease (ARD) due to 2019 novel
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …

[HTML][HTML] Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide …

…, Z Xie, Z Ni, Y Hu, L Liu, H Shan, C Lei… - European …, 2020 - Eur Respiratory Soc
Background During the outbreak of coronavirus disease 2019 (COVID-19), consistent and
considerable differences in disease severity and mortality rate of patients treated in Hubei …

Effect of recombinant human granulocyte colony–stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: a randomized clinical …

L Cheng, W Guan, C Duan, N Zhang, C Lei… - JAMA internal …, 2021 - jamanetwork.com
Importance Lymphopenia is common and correlates with poor clinical outcomes in patients
with coronavirus disease 2019 (COVID-19). Objective To determine whether a therapy that …

[HTML][HTML] Factors associated with duration of hospital stay and complications in patients with COVID-19

…, B Zhang, H Dong, JY Lu, CL Lei… - Journal of Public …, 2021 - jphe.amegroups.org
Background: Medical resources have been exhausted in many countries because of the
current worldwide pandemic of coronavirus disease 2019 (COVID-19). The identification of …

[HTML][HTML] Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized …

…, JD Xue, DW Mao, Q Li, HZ Yang, H Guo, CL Lei… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance The AnluoHuaxian pill (AHP) is a widely used patented
medicine for chronic hepatitis B (CHB) patients with advanced fibrosis or cirrhosis that has …

[HTML][HTML] Serum amyloid A is a predictor for prognosis of COVID‐19

XN Mo, ZQ Su, CL Lei, DF Chen, H Peng… - Respirology (Carlton …, 2020 - ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) outbreak originated in Wuhan, China, in December
2019. It has now affected 197 countries. By 27 April 2020, it was reported that 2 878 196 …

[HTML][HTML] Maternal and fetal exposure to cadmium, lead, manganese and mercury: the MIREC study

TE Arbuckle, CL Liang, AS Morisset, M Fisher, H Weiler… - Chemosphere, 2016 - Elsevier
Given the susceptibility of the fetus to toxicants, it is important to estimate their exposure.
Approximately 2000 pregnant women were recruited in 2008–2011 from 10 cities across …

Cohort profile: the maternal‐infant research on environmental chemicals research platform

TE Arbuckle, WD Fraser, M Fisher… - Paediatric and …, 2013 - Wiley Online Library
Background The M aternal‐ I nfant R esearch on E nvironmental C hemicals ( MIREC ) S
tudy was established to obtain C anadian biomonitoring data for pregnant women and their …